NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up
NCT01977014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2017-07-07
Summary
This observational study aims to chart patients which get their prostacyclin treatment via the subcutaneous LenusPro pump. How the surgical procedure is performed and the clinical follow-up of these patients. And by this also charting complications that might occur in relation to treatment.
Participating centres are located in Denmark, Norway and Sweden.
Conditions
- Pulmonary Hypertension Group 1 and 4 According to Nice Classification
Sponsors & Collaborators
-
NordicInfu Care AB
lead INDUSTRY
Principal Investigators
-
Jorn Carlsen, MD · Department of Cardiology, Rigshospitalet in Copenhagen
-
Gerhard Vikstrom, MD · Department of Cardiology, Uppsala Akademiska University Hospital
-
Arne Andreassen, MD · Department of Cardiology, Oslo University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Denmark
- Norway
- Sweden
Study Locations
More Related Trials
-
Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device
NCT04753112 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
NCT05147805 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
NCT05176951 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients
NCT06445673 ·Status: ENROLLING_BY_INVITATION
-
Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
NCT03015402 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
NCT05427162 ·Status: COMPLETED ·Phase: PHASE1
-
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
NCT01894035 ·Status: COMPLETED
-
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
NCT01645826 ·Status: WITHDRAWN ·Phase: NA
-
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
NCT00879229 ·Status: TERMINATED ·Phase: PHASE3
-
A First-in-Human Study to Assess the Safety and Tolerability of PDNO
NCT04891354 ·Status: COMPLETED ·Phase: PHASE1
-
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05649722 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
NCT06137742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure
NCT03714776 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension
NCT04715113 ·Status: COMPLETED ·Phase: NA
-
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
NCT05649748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
NCT00848731 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH
NCT03556020 ·Status: TERMINATED ·Phase: PHASE2
-
Pulmonary Hypertension: Assessment of Cell Therapy
NCT00469027 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT03794583 ·Status: TERMINATED ·Phase: PHASE3
-
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
NCT03795428 ·Status: TERMINATED ·Phase: PHASE2
-
Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
NCT00185315 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
NCT01971450 ·Status: COMPLETED
-
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
NCT01728220 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride
NCT03410420 ·Status: COMPLETED ·Phase: PHASE1
-
Simvastatin as a Treatment for Pulmonary Hypertension
NCT00180713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2